ITGAX and atherosclerosis: A study by Gautier et al. using transgenic animals with BcL-2 expression under a CD11c promoter, which causes in vivo expansion of DCs, showed reduction of atherosclerosis, which suggests that DCs are protective (Gautier et al., 2009).